Skip to main content
Clinical Trials/NCT02790931
NCT02790931
Completed
Not Applicable

Effects of Foot Muscle Strengthening in Daily Activity, Biomechanics and Functionality of Foot and Ankle in Diabetic Polyneuropathy Patients: a Randomized Controlled Trial

University of Sao Paulo General Hospital1 site in 1 country78 target enrollmentAugust 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Neuropathies
Sponsor
University of Sao Paulo General Hospital
Enrollment
78
Locations
1
Primary Endpoint
Self Selected Gait Speed
Status
Completed
Last Updated
last year

Overview

Brief Summary

The main objective of this trial is to investigate the effects of foot muscle strengthening in daily activity of patients with diabetic neuropathy.

Detailed Description

A randomized controlled trial will be performed with 77 patients with diabetic neuropathy. The participants will be randomly assigned into either a control group (recommended foot care by international consensus with no exercises) or an intervention group which will receive 12-week physical therapy exercises, twice a week, under the supervision of a physiotherapist, and twice a week being remotely supervised by a software at home. Every exercise has its own progression depending on the subjects' execution, increasing in intensity and difficulty. The subjects will be evaluated in 5 different moments (Baseline, 6 weeks, 12 weeks, 24 weeks and 1 year follow-up) The hypothesis of this study is that the intervention group will increase daily activity levels, increase self-selected and rapid walking speed, reduce the incidence of plantar ulcers, increase foot health and functionality, improve symptoms, increase tactile and vibration sensitivity, increased passive range of motion, improved quality of life, increased isometric strength of the feet and production of beneficial biomechanical changes during walking compared to the control group after 12 weeks of intervention and follow-up year.

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
December 2020
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Isabel de Camargo Neves Sacco

Associate Professor

University of Sao Paulo General Hospital

Eligibility Criteria

Inclusion Criteria

  • Diabetes mellitus type 1 or 2
  • Moderate or severe polyneuropathy confirmed with the fuzzy software
  • Ability to walk independently in the laboratory
  • Accessibility to electronic devices
  • Loss of at least 4 degrees of ankle range of motion
  • Loss of at least 1 degree of force in the clinical scale of the plantar interosseous or lumbrical muscles

Exclusion Criteria

  • Ulceration not healed for at least 6 months
  • Hallux amputation or total amputation of the foot
  • Receiving any physiotherapy intervention or offloading devices
  • Neurological or orthopedic impairments
  • Major vascular complications
  • Severe retinopathy

Outcomes

Primary Outcomes

Self Selected Gait Speed

Time Frame: 12 weeks

self selected gait speed shod walking velocity in a walkway

Fast Gait Speed

Time Frame: 12 weeks

Fast gait speed shod walking velocity in a walkway

Daily Physical Activity

Time Frame: 12 weeks

Calculate the number of steps per week

Secondary Outcomes

  • Foot and Ankle Kinematics During Gait(baseline, 12 weeks)
  • Plantar Ulcers(12 months)
  • Tactile Sensitivity(12 weeks)
  • Range of Motion(12 weeks)
  • Risk Classification of Plantar Ulceration(12 weeks)
  • Foot Health and Functionality(12 weeks)
  • Foot Strength(12 weeks)
  • Ankle and Knee Joint Moments and Power During Gait(baseline, 12 weeks)
  • Vibration Sensitivity(12 weeks)
  • Neuropathy Symptoms(12 weeks)
  • EQ-5D Score(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials